31.45+1.0 (+3.11%)
26 Aug, 2:30 PM

Annual Reports and Financial Documents

Maxposure Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
20242025
Annual Reports
Quarterly Results
Conference Calls
Presentations

Corporate Announcements and Regulatory Filings

Maxposure Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  1. Acquisition16 Jul 2026
    Maxposure Limited has informed the exchange about acquisition of additional 3.8% equity stake in Netrual Digital Limited (Target Company)
  2. Press Release14 Jul 2026
    Maxposure Limited has informed the Exchange regarding a press release dated July 14, 2026, titled Myanmar Airways International Partners with Aerohub & Aeroplay to Launch Wireless In-Flight Entertainment.
  3. Certificate under SEBI (Depositories and Participants) Regulations, 20188 Jul 2026
    Maxposure Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th June, 2026
  4. Updates18 Jun 2026
    Maxposure Limited has informed the Exchange regarding 'Intimation of Appointment of Investor Relations and Public Relations Agency.'
  5. Disclosure under SEBI Takeover Regulations15 Jun 2026
    Maxposure Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
  6. Structural Digital Database28 May 2026
    SDD Compliance Certificate for the financial year ended on March 31, 2026 (Pursuant toSecurities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015
  7. Change in Auditors26 May 2026
    Maxposure Limited has informed the Exchange regarding Change in Auditors of the company.
  8. Related Party Transactions26 May 2026
    Maxposure Limited has informed the Exchange about related Party Transactions
  9. Integrated Filing- Financial26 May 2026
    Integrated Filing (Financials)
  10. Statement of deviation(s) or variation(s) under Reg. 3226 May 2026
    Maxposure Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32
  11. Utilisation of Funds26 May 2026
    Maxposure Limited has informed the Exchange about Utilisation of Funds
  12. Outcome of Board Meeting26 May 2026
    Maxposure Limited has informed the Exchange regarding Outcome of Board Meeting held on May 26, 2026.
  13. Outcome of Board Meeting26 May 2026
    Maxposure Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
  14. Updates22 May 2026
    Maxposure Limited has informed the Exchange regarding ''Non-applicability of ASCR
  15. Updates30 Apr 2026
    Maxposure Limited has informed the Exchange regarding 'Declaration for Non-Applicability of Corporate Governance Provisions for FY 2026 27 (Integrated Filing Governance)'.
  16. Updates29 Apr 2026
    Maxposure Limited has informed the Exchange regarding 'Confirmation of Non-Applicability as a Large Corporate / Large Entity '.
  17. Certificate under SEBI (Depositories and Participants) Regulations, 201814 Apr 2026
    Maxposure Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  18. Updates8 Apr 2026
    Maxposure Limited has informed the Exchange regarding 'Disclosure under Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011' for the year ended on 31st March, 2026
  19. Trading Window25 Mar 2026
    Maxposure Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
  20. Updates25 Mar 2026
    Maxposure Limited has informed the Exchange regarding ''Application to NSE Emerge- Change/ Appointment of New Market Maker.

Frequently Asked Questions

Where can I download the annual report of Maxposure Ltd.?
Annual reports of Maxposure Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Maxposure Ltd.?
Quarterly earnings results and presentations of Maxposure Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Maxposure Ltd. publish earnings call transcripts?
Earnings call transcripts of Maxposure Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Maxposure Ltd.?
Investor presentations and annual day presentations of Maxposure Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Maxposure Ltd.?
Corporate announcements and regulatory filings of Maxposure Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Maxposure Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Maxposure Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Maxposure Ltd.?
The ISIN (International Securities Identification Number) of Maxposure Ltd. is INE0ECC01022. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Maxposure Ltd. listed?
Maxposure Ltd. is listed on NSE and BSE. The NSE symbol is MAXPOSURE and the BSE code is -.
Where can I find the shareholding pattern of Maxposure Ltd.?
The quarterly shareholding pattern of Maxposure Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Maxposure Ltd. on Sharpely?
Share price data for Maxposure Ltd. is updated as of 26 Aug 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.